Hczzen-300 is a specialized therapeutic agent featuring Hydroxychloroquine Sulphate, widely recognized for its dual role as an anti-malarial and a potent Disease-Modifying Anti-Rheumatic Drug (DMARD). It is highly effective in managing chronic autoimmune conditions such as rheumatoid arthritis, systemic lupus erythematosus (SLE), and discoid lupus. By modulating the overactive immune system, Hczzen-300 significantly reduces joint pain, inflammation, and skin-related complications. Its unique mechanism helps in preventing long-term tissue damage and flare-ups associated with autoimmune disorders. Given its systemic impact, long-term use requires regular clinical monitoring, including periodic eye examinations and blood tests to ensure patient safety. Hczzen-300 is designed to provide sustained relief and improve the functional capacity of patients, making it a cornerstone of comprehensive orthopedic and rheumatological care within the Human Orthocare division. It empowers patients to achieve better disease control and a more stable, pain-free lifestyle under expert medical guidance.